CN Patent

CN117616023A — Bcl-2或bcl-2/bcl-xl调节剂及其用途

Assigned to Xunya Co ltd · Expires 2024-02-27 · 2y expired

What this patent protects

调节BCL‑2蛋白或BCL‑2/BCL‑XL蛋白的水平或活性的式I化合物，包含一种或多种所述化合物的药物组合物及其用途。

USPTO Abstract

调节BCL‑2蛋白或BCL‑2/BCL‑XL蛋白的水平或活性的式I化合物，包含一种或多种所述化合物的药物组合物及其用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN117616023A
Jurisdiction
CN
Classification
—
Expires
2024-02-27
Drug substance claim
No
Drug product claim
No
Assignee
Xunya Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.